Chong Kun Dang signs co-sales agreement of dementia therapy ‘Aricept’ with Eisai Korea

Published: 2018-05-30 17:57:13

Updated: 2018-05-30 17:57:13

Chong Kun Dang(CEO Young-Joo Kim) signed a co-sales agreement of dementia therapies ‘Aricept’ and ‘Aricept Evess’ with Eisai Korea at the Chong Kun Dang’s headquarters located in Chungjeongno, Seoul on the 28^th.

Under the agreement, Chong Kun Dang will take over sales and marketing activities for the two products at local clinics, and Eisai Korea have the same activities at general hospitals.

...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.